As Isomorphic Labs aims its artificial intelligence tools at drug development, it’s setting up a new outpost in the biotech ...

Kraft Heinz will be pulling artificial dyes from its U.S. products starting in 2027 and will no longer roll out new products with the dyes. The move comes nearly two months after U.S. health officials ...

Aldeyra Therapeutics (NASDAQ:ALDX) said that it has resubmitted its marketing application to the U.S. FDA for its dry eye ...

Kraft Heinz Co. said it will remove synthetic food dyes from all of its US products by the end of 2027, eliminating ...

Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...

Kraft Heinz said it will remove artificial dyes from its U.S. products by end of 2027 and stop making new products that ...

The Johns Hopkins-led and NIH funded OUtMATCH study led to the development of Xolair, a groundbreaking drug that reduces the ...

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

Musk's post to social media is the latest in a series of posts relating to the Tesla CEO's alleged drug use, following a report from The New York Times.

Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...

On June 10, 2025, the Commissioner of the FDA, Dr. Martin Makary, and Dr. Vinayak Prasad, the Director of the FDA’s Center ...